U.S. Near Infrared Imaging Market (By Product: Device, Reagents; By Application: Cancer Surgeries, Gastrointestinal Surgeries; By End-use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

U.S. Near Infrared Imaging Market Size and Forecast

The U.S. near infrared imaging market size was valued at USD 0.78 billion in 2023 and it is predicted to surpass around USD 1.16 billion by 2033 with a CAGR of 4.03% from 2024 to 2033.

Key Pointers

• By Product, the reagents segment held the largest revenue share of 57% in 2023.
• By Product, the devices segment is expected to grow significantly from 2024 to 2033.
• By Application, the preclinical imaging registered the maximum market share of 26% in 2023.
• By Application, the cancer surgeries segment is anticipated to grow at the fastest CAGR from 2024 to 2033.
• By End-Use, the hospitals and clinics contributed the largest market share of 45% in 2023.
• By End-Use, the pharmaceutical and biotechnology companies segment is poised for significant growth from 2024 to 2033.

U.S. Near Infrared Imaging Market Overview

Near Infrared (NIR) imaging technology has gained significant traction in the United States across various industries, including healthcare, agriculture, and surveillance. This non-invasive imaging technique utilizes near-infrared light to capture detailed images beyond what is visible to the human eye, offering valuable insights into biological tissues, materials, and objects.

U.S. Near Infrared Imaging Market Growth Factors

The growth of the U.S. Near Infrared (NIR) imaging market is driven by an advancements in healthcare applications have significantly boosted demand, with NIR imaging facilitating enhanced diagnostics and surgical procedures, thereby improving patient outcomes. Additionally, expanding applications in agriculture for crop assessment and in industrial sectors for quality control have contributed to market expansion. Moreover, the rising need for enhanced security and surveillance solutions has spurred the adoption of NIR imaging technologies, further driving market growth. These factors, coupled with ongoing technological advancements and regulatory support, are expected to sustain the upward trajectory of the U.S. NIR imaging market in the foreseeable future.

U.S. Near Infrared Imaging Market Trends:

• Advancements in Healthcare Applications: NIR imaging is increasingly used for real-time diagnostics and surgical guidance, improving precision and patient outcomes.
• Expansion in Agriculture: NIR imaging aids in assessing crop health, optimizing yield, and monitoring soil conditions, driving its adoption in agriculture.
• Industrial Quality Control: Industries utilize NIR imaging for non-destructive testing, ensuring product quality and consistency in manufacturing processes.
• Security and Surveillance Applications: NIR cameras are integral to enhancing security measures, providing clear imaging in low-light conditions for effective surveillance.
• Technological Innovations: Ongoing advancements in NIR imaging technology, including improved sensors and image processing capabilities, are driving market growth.

Product Insights

In 2023, reagents dominated the market with a commanding 57% share, projected to exhibit the fastest CAGR throughout the forecast period. This growth is fueled by their superior efficacy in biological systems, strong tissue penetration capabilities, and the growing trend towards detailed imaging. Reagents play a critical role in image-guided interventions in clinical settings, particularly in real-time cancer detection. Research institutions are actively developing innovative imaging techniques using these reagents, which promise improved patient outcomes. For instance, in January 2023, researchers at Rice University introduced a new fluorescent dye for non-invasive brain imaging.

The devices segment is expected to grow significantly from 2024 to 2033, driven by advancements in NIR systems designed for surgical applications. These devices, including near-infrared fluorescence and bioluminescence imaging systems, offer non-invasive, radiation-free imaging solutions, driving their adoption in clinical settings.

Application Insights

Preclinical imaging held the largest market share of 26% in 2023, driven by increasing studies focused on diseases such as cancer, inflammation, and infectious diseases. The adoption of advanced reagents with deep tissue penetration capabilities is enhancing their utility in preclinical research. NIR imaging is also gaining traction in clinical studies for detecting active pharmaceutical ingredients (APIs). For example, a June 2023 study highlighted the use of indocyanine green-enhanced fluorescence to assess bowel perfusion during robotic-assisted rectal surgery.

The cancer surgeries segment is anticipated to grow at the fastest CAGR from 2024 to 2033, driven by the critical role of NIR imaging in intraoperative cancer detection. NIR systems enable precise visualization of tumor cells, vascular structures, and other critical anatomical features, facilitating accurate tumor resection. The segment's growth is further bolstered by the increasing number of cancer surgeries performed annually in the U.S., surpassing 700,000 according to Clinical Research Cancer.

End-Use Insights

Hospitals and clinics dominated the end-use market with a 45% share in 2023, driven by the rising prevalence of cancer and plastic surgeries. NIR technology is integral to these healthcare settings, aiding in the detection of bedsores and preventing surgical errors, thereby contributing to segment growth. Increased funding for research and grants aimed at developing infrared technologies for hospital applications is expected to further fuel market expansion.

The pharmaceutical and biotechnology companies segment is poised for significant growth from 2024 to 2033. NIR technology finds diverse applications in these sectors, including raw material identification, quality verification of lyophilized materials, monitoring of tablet coating and content, as well as in-line and on-line process monitoring. These applications are anticipated to drive demand for NIR systems in pharmaceutical and biotechnology industries in the coming years.

U.S. Near Infrared Imaging Market Key Companies

• Stryker
• PerkinElmer, Inc
• Li-Cor, Inc.
• PerkinElmer, Inc.
• Leica Microsystems
• Intuitive Surgical
• Avantor®
• ICG Pharmaceutical
• Veranova
• CalBiotech

Recent Developments

• In July 2023, Nikon In October 2023, as per the research article published in the Journal of Imaging concluded that Near-infrared fluorescence imaging can be a potential tool for the detection of glioblastoma in preclinical models.
• June 2022, Stryker Endoscopy Latam Franchise announced the launch of the +FOCO Campaign to offer an informative session about fluoresce dye i.e. INDOCIANINE GREEN FLURESCENCE.

U.S. Near Infrared Imaging Market Segmentation:

By Product

• Device
• Near-Infrared Fluorescence Imaging Systems
• Near-Infrared Fluorescence & Bioluminescence Imaging Systems
• Reagents
• Indocyanine Green (ICG)
• Other Reagents

By Application

• Preclinical Imaging
• Cancer Surgeries
• Gastrointestinal Surgeries
• Cardiovascular Surgeries
• Plastic/Reconstructive Surgeries
• Other Applications

By End-use

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Research Laboratories